Medical devices, healthcare technology and the business of care
510(k) clearance · K261870

ANNE Limb

Sibel Health · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONK261870

What did the FDA decide?

The FDA's 510(k) database records K261870 for the device named ANNE Limb, submitted by Sibel Health of Chicago, Illinois. The record lists the device classification name as Oximeter under regulation 870.2700, with primary product code DQA and subsequent product codes DRG and FLL. The regulation medical specialty and review panel are both recorded as Cardiovascular, and the submission type is Traditional, with no third-party review, no combination product designation and no authorized predetermined change control plan.

The application was received on 06/04/2026 and decided on 11/05/2026 as Substantially Equivalent (SESE), which is a 510(k) clearance rather than a premarket approval. The page does not state which predicate device was used, what the specific component or changed item was, or what indications the clearance covers; those details would need the underlying decision documents. The page was last updated 11/16/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Nov 5, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261870
Regulatory pathway
510(k) premarket notification
Applicant
Sibel Health
Product code
DQA
Decision code
SESE
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Oximeter.

Applicant
Sibel Health
Product code
DQA
FDA device class
2

FDA decision timeline

  1. K261870 received

    Application receipt date recorded by FDA.

  2. K261870 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sibel Health

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Chicago, IL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records